Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders

• Published in: Experimental neurology 2021-08, Vol.342, p.113758-113758, Article 113758
• Main Authors: Altamura, Concetta, Fonzino, Adriano, Tarantino, Nancy, Conte, Elena, Liantonio, Antonella, Imbrici, Paola, Carratù, Maria Rosaria, Pierno, Sabata, Desaphy, Jean-François
• Format: Article
• Language: English
• Subjects: Acetazolamide; Carbonic anhydrase inhibitors; ClC-1 chloride channel; Dichlorphenamide; Myotonia; Sarcolemma excitability
• ISSN: 0014-4886; 1090-2430
• DOI: 10.1016/j.expneurol.2021.113758

To get insight into the mechanism of action of carbonic anhydrase inhibitors (CAI) in neuromuscular disorders, we investigated effects of dichlorphenamide (DCP) and acetazolamide (ACTZ) on ClC-1 chloride channels and skeletal muscle excitability. We performed patch-clamp experiments to test drugs on chloride currents in HEK293T cells transfected with hClC-1. Using the two-intracellular microelectrode technique in current-clamp mode, we measured the effects of drugs on the resting chloride conductance and action potential properties of sarcolemma in rat and mouse skeletal muscle fibers. Using BCECF dye fluorometry, we measured the effects of ACTZ on intracellular pH in single rat muscle fibers. Similarly to ACTZ, DCP (100 μM) increased hClC-1 chloride currents in HEK cells, because of the negative shift of the open probability voltage dependence and the slowing of deactivation kinetics. Bendroflumethiazide (BFT, 100 μM), structurally related to DCP but lacking activity on carbonic anhydrase, had little effects on chloride currents. In isolated rat muscle fibers, 50–100 μM of ACTZ or DCP, but not BFT, induced a ~ 20% increase of the resting chloride conductance. ACTZ reduced action potential firing in mouse muscle fibers. ACTZ (100 μM) reduced intracellular pH to 6.8 in rat muscle fibers. These results suggest that carbonic anhydrase inhibitors can reduce muscle excitability by increasing ClC-1 channel activity, probably through intracellular acidification. Such a mechanism may contribute in part to the clinical effects of these drugs in myotonia and other muscle excitability disorders. [Display omitted] •Dichlorphenamide increases chloride currents in HEK cells expressing ClC-1 channel.•Dichlorphenamide increases sarcolemma chloride conductance in skeletal muscle fibers.•Acetazolamide reduces action potential firing in mouse skeletal muscle fibers.•Acetazolamide reduces intracellular pH in rat skeletal muscle fibers.•Carbonic anhydrase inhibitors may dampen muscle excitability though chloride channel activation.